Alan W. Partin, M.D., Ph.D.
Alan W. Partin, M.D., Ph.D., is director of the James Buchanan Brady Urological Institute at Johns Hopkins. His focus is on the development and testing of new and existing methods for predicting the aggressiveness of prostate cancers so that patients and their physicians can make rational treatment decisions.
Latest by Alan W. Partin, M.D., Ph.D.
There are many tests out there to help diagnose prostate cancer, but it’s not yet clear how useful they are. Here’s what to consider.